Barclays’s Elevance Health ELV Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | $179M | Sell |
|
|||||
|
2025
Q2 | $231M | Buy |
|
|||||
|
2025
Q1 | $219M | Buy |
|
|||||
|
2024
Q4 | $166M | Sell |
|
|||||
|
2024
Q3 | $323M | Sell |
|
|||||
|
2024
Q2 | $536M | Sell |
|
|||||
|
2024
Q1 | $532M | Sell |
|
|||||
|
2023
Q4 | $582M | Buy |
|
|||||
|
2023
Q3 | $476M | Sell |
|
|||||
|
2023
Q2 | $561M | Buy |
|
|||||
|
2023
Q1 | $380M | Buy |
|
|||||
|
2022
Q4 | $400M | Buy |
|
|||||
|
2022
Q3 | $206M | Buy |
|
|||||
|
2022
Q2 | $168M | Sell |
|
|||||
|
2022
Q1 | $237M | Sell |
|
|||||
|
2021
Q4 | $302M | Buy |
|
|||||
|
2021
Q3 | $235M | Buy |
|
|||||
|
2021
Q2 | $197M | Buy |
|
|||||
|
2021
Q1 | $163M | Buy |
|
|||||
|
2020
Q4 | $120M | Buy |
|
|||||
|
2020
Q3 | $84.5M | Buy |
|
|||||
|
2020
Q2 | $67.8M | Sell |
|
|||||
|
2020
Q1 | $63.8M | Sell |
|
|||||
|
2019
Q4 | $143M | Sell |
|
|||||
|
2019
Q3 | $136M | Sell |
|
|||||
|
2019
Q2 | $181M | Buy |
|
|||||
|
2019
Q1 | $145M | Buy |
|
|||||
|
2018
Q4 | $97.7M | Sell |
|
|||||
|
2018
Q3 | $115M | Sell |
|
|||||
|
2018
Q2 | $116M | Sell |
|
|||||
|
2018
Q1 | $135M | Buy |
|
|||||
|
2017
Q4 | $105M | Buy |
|
|||||
|
2017
Q3 | $65.4M | Sell |
|
|||||
|
2017
Q2 | $78.1M | Sell |
|
|||||
|
2017
Q1 | $71.5M | Buy |
|
|||||
|
2016
Q4 | $38.4M | Buy |
|
|||||
|
2016
Q3 | $32.2M | Sell |
|
|||||
|
2016
Q2 | $56.6M | Buy |
|
|||||
|
2016
Q1 | $39.6M | Buy |
|
|||||
|
2015
Q4 | $32.7M | Buy |
|
|||||
|
2015
Q3 | $23.6M | Sell |
|
|||||
|
2015
Q2 | $51.8M | Sell |
|
|||||
|
2015
Q1 | $57.7M | Buy |
|
|||||
|
2014
Q4 | $42.3M | Sell |
|
|||||
|
2014
Q3 | $56.3M | Sell |
|
|||||
|
2014
Q2 | $50.7M | Sell |
|
|||||
|
2014
Q1 | $57.3M | Sell |
|
|||||
|
2013
Q4 | $65M | Buy |
|
|||||
|
2013
Q3 | $53.2M | Buy |
|
|||||
|
2013
Q2 | $46.5M | Buy |
|